1. Home
  2. YDES vs LTBR Comparison

YDES vs LTBR Comparison

Compare YDES & LTBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YDES

YD Bio Limited Ordinary Shares

HOLD

Current Price

$2.32

Market Cap

543.0M

Sector

N/A

ML Signal

HOLD

Logo Lightbridge Corporation

LTBR

Lightbridge Corporation

HOLD

Current Price

$7.54

Market Cap

575.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
YDES
LTBR
Founded
2013
1992
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Professional Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
543.0M
575.6M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
YDES
LTBR
Price
$2.32
$7.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
312.1K
764.2K
Earning Date
05-12-2026
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$6.92
52 Week High
$25.00
$31.34

Technical Indicators

Market Signals
Indicator
YDES
LTBR
Relative Strength Index (RSI) 44.84 38.04
Support Level $2.14 $6.92
Resistance Level $3.05 $9.43
Average True Range (ATR) 0.32 0.52
MACD 0.07 0.07
Stochastic Oscillator 59.36 29.21

Price Performance

Historical Comparison
YDES
LTBR

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

About LTBR Lightbridge Corporation

Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.

Share on Social Networks: